Furthermore, TRPV2 expression in CD34+/CD45+/CD133+/CD73+ hematopoietic stem cells, from which all lineages of blood cells are derived, suggests a role for this channel in hematopoietic cell-derived tumors, i.e., leukemias and lymphomas [20]. The gene discussed is TRPV2; the disease is leukemia.